Cover Image
市場調查報告書

藥物研發的全球市場:各國(美國、加拿大、印度、中國、日本、英國)、企業簡介、佔有率、趨勢、分析、機會、市場區隔及2015∼2021年的預測

Global Drug Discovery Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 345951
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
藥物研發的全球市場:各國(美國、加拿大、印度、中國、日本、英國)、企業簡介、佔有率、趨勢、分析、機會、市場區隔及2015∼2021年的預測 Global Drug Discovery Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年03月20日 內容資訊: 英文 140 Pages
簡介

藥物研發及藥物開發是製藥公司和生物科技企業的重要功能。藥物研發計劃由於通常要經由標的鑑定、驗證、臨床實驗、登記、認證等手續,藥物正式上市之前需要15年之久。現在,全球藥物研發市場上,北美企業有最大的市場佔有率。

本報告提供全球藥物研發市場相關調查、市場趨勢以及到2021年的收益預測與成長率、產業分析、競爭趨勢、各地區趨勢,及進入的主要企業簡介彙整。

第1章 簡介

第2章 市場概要

  • 主要調查結果
  • 價值鏈分析
  • 主要的購買標準
  • 藥物研發開發平台流程
    • 標的事前發現
    • 化合物發現
    • 領導化合物發現和最佳化
    • 事前臨床研究
    • 臨床實驗
    • 申請/認證
    • 製造
    • 上市
  • 策略性建議
  • 策略性結論
  • 藥物研發市場上出貨趨勢
  • 預測趨勢與新興市場

第3章 市場決策因素

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場課題
  • 市場機會

第4章 市場區隔

  • 各服務類別
    • 生物學的服務
    • 化學的服務
    • 藥學服務
    • 藥物代謝、藥物動力學服務
  • 各科學
    • 蛋白質體學
    • 基因學
    • 生物資訊學
  • 各技術
    • QPCR
    • DNA及蛋白質微陣列
    • 高通量篩檢
    • 質譜分析
    • 實驗室資訊管理系統
    • 微流體
    • 凝膠電子游泳動
    • 層析法
    • 蛋白質及核酸隔離
    • 其他
  • 新技術

第5章 市場佔有率與策略

第6章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 企業分析

  • Sanofi
  • Johnson and Johnson
  • AstraZeneca
  • Bayer
  • BohringerIngheliem
  • Pfizer
  • GlaxoSmithKline
  • Eli Lily
  • Albany Molecular Research
  • Charles River Laboratories
  • Covance
  • Cyprotex
  • EVT innovate
  • Gen Script
  • Pharmaceutical Product Development
  • Quintiles
  • Viva Biotech
  • WIL research Laboratories
  • WUXI Apptech

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ?HPH-990915

Drug discovery and development are key functions of pharmaceutical and biotechnology companies. Drug discovery programs are essential for the introduction of new drugs. As more number of patients are diagnosed with new symptoms and syndromes. Drug discovery programs are usually lengthy and involve target identification, target validation, clinical trials, registration and approval. The whole process takes 15 years before the drug is officially launched and marketed. It is important for the governments to make their processes more coherent and less time consuming. Also, policies should be made to make data sharing more efficient. Drugs discovery should be made cheaper by relaxing tax laws, decreasing duties on instrument exports, increasing government and private funding. Introduction of new drugs and changes in the laws can lead to reduced cost and pricing of new target drugs.

At present North American companies have the highest market share in the overall drug discovery market. Major drug discovery technology and service providers are established in the U.S. The market is driven by presence of manufacturing facilities and research labs of major drug manufacturers. North America is also the highest consumer of branded drugs. The assistance of government regulatory bodies and high level of awareness related to life threatening diseases also encourage drug manufacturers to work on target drug discovery. Similar factors along with common regulations across Europe are responsible for a well-developed market. European research labs and institutes are driven by favourable environment provided by the European Union. Chinese, Japanese and Indian companies are providing contract research services to major pharmaceutical companies in the West. China is the leading Asian country as major international pharmaceutical companies are building their manufacturing facilities in China.

Companies profiled include:

  • 1. Sanofi
  • 2. Johnson and Johnson
  • 3. AstraZeneca
  • 4. Bayer
  • 5. BohringerIngheliem
  • 6. Pfizer
  • 7. GlaxoSmithKline
  • 8. Eli Lily
  • 9. Albany Molecular Research
  • 10. Charles River Laboratories
  • 11. Covance
  • 12. Cyprotex
  • 13. EVT innovate
  • 14. Gen Script
  • 15. Pharmaceutical Product Development
  • 16. Quintiles
  • 17. Viva Biotech
  • 18. WIL research Laboratories
  • 19. WUXI Apptech

This Occams Research Report covers

  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR upto 2022
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data
  • 6. In-depth profiling of companies

Table of Contents

1. Introduction

  • 1.1. Executive Summary
  • 1.2. Estimation Methodology

2. Market Overview

  • 2.1. Key findings
  • 2.2. Value Chain analysis
  • 2.3. Key buying criteria
  • 2.4. Drug Discovery Pipeline Process
    • 2.4.1. Pre Discovery of target
    • 2.4.2. Compound Discovery
    • 2.4.3. Lead discovery and Optimization
    • 2.4.4. Pre Clinical Study
    • 2.4.5. Clinical Trials
    • 2.4.6. Application/Approval
    • 2.4.7. Manufacturing
    • 2.4.8. Market launch and Market
  • 2.5. Strategic recommendation
  • 2.6. Strategic conclusions
  • 2.7. Unit shipment in Drug Discovery market
  • 2.8. Forecasted trends and emerging markets

3. Market determinants

  • 3.1. Market drivers
  • 3.2. Market restraints
  • 3.3. Market challenges
  • 3.4. Market opportunities

4. Market Segmentation

  • 4.1. By Service
    • 4.1.1. Biological Services
    • 4.1.2. Chemical Services
    • 4.1.3. Pharmaceutical Services
    • 4.1.4. Drug Metabolism and Pharmacokinetics (DMPK) Services
  • 4.2. By Science
    • 4.2.1. Proteomics
    • 4.2.2. Genomics
    • 4.2.3. Bioinformatics
  • 4.3. By technology
    • 4.3.1. QPCR
    • 4.3.2. DNA and protein microarrays
    • 4.3.3. High-throughput screening
    • 4.3.4. Mass spectrometry
    • 4.3.5. Laboratory information management systems
    • 4.3.6. Microfluidics
    • 4.3.7. Gel electrophoresis
    • 4.3.8. Chromatography
    • 4.3.9. Protein and nucleic acid isolation.
    • 4.3.10. Others
  • 4.4. Novel technologies:
    • 4.4.1. Back scattering interferometry
    • 4.4.2. Cantilever array

5. Market Share and Strategy

6. Geographical Analysis

  • 6.1. North America
    • 6.1.1. United States (U.S.)
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. United Kingdom (UK)
    • 6.2.2. France
    • 6.2.3. Germany
    • 6.2.4. Spain
    • 6.2.5. Italy
  • 6.3. Asia Pacific
    • 6.3.1. India
    • 6.3.2. China
    • 6.3.3. Japan
    • 6.3.4. Korea
    • 6.3.5. Australia
  • 6.4. Rest of the world
    • 6.4.1. Latin America
    • 6.4.2. MENA
    • 6.4.3. Africa

7. Company Profiling:

  • 7.1. Sanofi
  • 7.2. Johnson and Johnson
  • 7.3. AstraZeneca
  • 7.4. Bayer
  • 7.5. BohringerIngheliem
  • 7.6. Pfizer
  • 7.7. GlaxoSmithKline
  • 7.8. Eli Lily
  • 7.9. Albany Molecular Research
  • 7.10. Charles River Laboratories
  • 7.11. Covance
  • 7.12. Cyprotex
  • 7.13. EVT innovate
  • 7.14. Gen Script
  • 7.15. Pharmaceutical Product Development
  • 7.16. Quintiles
  • 7.17. Viva Biotech
  • 7.18. WIL research Laboratories
  • 7.19. WUXI Apptech
Back to Top